The safety of double- and triple-drug community mass drug administration for lymphatic filariasis: A multicenter, open-label, cluster-randomized study.
Gary J WeilJoshua BogusMichael ChristianChristine DubrayYenny DjuardiPeter U FischerCharles W GossMyra HardyPurushothaman JambulingamChristopher L KingVijesh Sridhar KuttiatKaliannagounder KrishnamoorthyMoses LamanJean Frantz LemoineKatiuscia K O'BrianLeanne J RobinsonJosaia SamuelaKenneth B SchechtmanAnita SircarAdinarayanan SrividyaAndrew C SteerTaniawati SupaliSwaminathan Subramaniannull nullPublished in: PLoS medicine (2019)
Clinicaltrials.gov registration number: NCT02899936.